Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb;406(1):171-179.
doi: 10.1007/s00423-020-01949-1. Epub 2020 Aug 6.

One anastomosis gastric bypass vs. Roux-en-Y gastric bypass: a 5-year follow-up prospective randomized trial

Affiliations
Randomized Controlled Trial

One anastomosis gastric bypass vs. Roux-en-Y gastric bypass: a 5-year follow-up prospective randomized trial

Luis Level et al. Langenbecks Arch Surg. 2021 Feb.

Abstract

Background: One anastomosis gastric bypass (OAGB) is a relatively novel technique with excellent outcomes, comparable to most accepted procedures. Our aim was to compare OAGB and Roux-en-Y gastric bypass (RYGB) in terms of percent of excess weight lost (%EWL) and resolution of comorbidities.

Methods: Thirty-three patients were randomly assigned (1:2) to two groups (OAGB = 9 and RYGB = 24). Patients were analyzed prospectively.

Results: The 5-year follow-up was 85% (28 patients). Both groups were comparable preoperatively in age, weight, body mass index (BMI), and excess weight. One intraoperative complication in OAGB group and no major postoperative complications for both groups were recorded. Progressive decrease in weight, BMI, and %EWL was observed at 1, 6, 12 months, and 5 years, with no differences between groups. Regarding comorbidities, we registered complete remission in type 2 diabetes mellitus (T2DM), insulin resistance, and dyslipidemia with OAGB. RYGB group reported complete remission in T2DM, insulin resistance, dyslipidemia, and gastroesophageal reflux disease (GERD). Mean operative time were 113.3 min ± 41.2 and 143.7 min ± 21.85 for OAGB and RYGB respectively. Mean number of reloads used was 5 for OAGB and 7 for RYGB, which demands further investigations. Postoperative pain was significantly higher in RYGB group. Hospital stay was 3 days for both groups.

Conclusion: At 5-year follow-up, patients of both techniques achieved similar outcomes in terms of %EWL and resolution of comorbidities, without early or mid-term major complications and no mortality. OAGB demonstrated less use of surgical stapling and unexplainably less postoperative pain compared to RYGB.

Keywords: Bariatric surgery; One-anastomosis gastric bypass; Roux-en-Y gastric bypass.

PubMed Disclaimer

References

    1. Schulz KF, Altman DG (2011) Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Int J Surg 9(8):672–677. https://doi.org/10.1016/j.ijsu.2011.09.004 - DOI - PubMed
    1. Garcia-Caballero M, Carbajo M (2004) One anastomosis gastric bypass: a simple, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp 19(6):372–375 - PubMed
    1. Cardoso RA, Galväo NM, Carlo A (2004) Simplified gastric bypass. 522 initial cases. Rev Mex Cir Endosc 5(1):36
    1. Brethauer SA, Kim J, el Chaar M et al (2015) Standardized outcomes reporting in metabolic and bariatric surgery. Obes Surg 25:587–606. https://doi.org/10.1007/s11695-015-1645-3 - DOI - PubMed
    1. Magouliotis DE, Tasiopoulou VS, Tzovaras G (2018) One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes 8(3):159–169. https://doi.org/10.1111/cob.12246 - DOI - PubMed

Publication types

LinkOut - more resources